Evidence map›Paper›PMID 42620694›Full record

ArticleAmerican journal of ophthalmology case reports2026

Steroid response after complete trabecular meshwork removal.

Sebastian Lacau, Alejandro M Perez, Elena Bitrian

Abstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sebastian LacauBascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Alejandro M PerezBascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Elena BitrianBascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Steroid-induced hypertensive response is a common, yet underdiagnosed complication of steroid therapy. Certain patients, referred to as high responders, can experience a rapid and severe rise in intraocular pressure (IOP) potentially reaching sight-threatening levels. This report presents two high-responder patients with multiple risk factors. Methods: Medical records of two patients who underwent 360° angle surgery and experienced postoperative IOP spikes were reviewed, and clinical data was extracted. Results: Two male patients aged 8 and 22 years old with juvenile open angle glaucoma (JOAG) with elevated IOP despite maximum medical therapy underwent gonioscopy-assisted transluminal trabeculotomy with canaloplasty in both eyes and were started postoperatively on prednisolone. Patient 1 had an IOP of 61 mmHg on postoperative day (POD) 6, prednisolone was discontinued, and treatment was switched to ketorolac, antiglaucoma drops and oral agents. Patient 2 had an IOP of 48 mmHg on POD 9 and IOP was controlled upon discontinuing prednisolone and glaucoma drops. His second eye was treated with fluorometholone after surgery but presented with an IOP of 39 mmHg on POD 8 and also switched to ketorolac. Both patients had controlled IOPs after steroid cessation. Conclusion: Steroid response can occur even in procedures targeting the trabecular meshwork. Identifying risk factors, including a glaucoma diagnosis, family history, young age, and use of potent steroids enables closer monitoring. Early detection and cessation of steroid therapy are crucial to preventing sustained IOP elevation, underscoring the importance of vigilance in high-risk patients.

Identifiers

PMID42620694
PMCPMC13486349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.